Welcome to the December edition of our newsletter!
Bringing you our latest discoveries in high-throughput screening, genomic and cellular analysis, colony selection, and microplate detection. Visit us at: moleculardevices.com
Safer, faster drug development with cell-based toxicity assessment methods
Toxicity assessment plays a critical role in the development of new drugs, as many potential treatments are found to be toxic in early clinical trials. Shifting to cell-based testing allows for multiple chemicals to be tested rapidly and better represents human biology. 3D organoids are especially useful due to their high complexity and better resemblance to human tissue structure and function. Consequently, moving away from animal testing and towards cell-based methods could provide more accurate results, saving time, money, and most importantly, lives.
Optimize your 3D culture workflows to deliver robust, reproducible results at scale
The need to reduce drug attrition rates and the use of animal experimentation has led to the development of more complex in vitro models such as organoids. However, due to their complexity, organoids introduce challenges that hinder their wider use in existing drug development workflows.
Listen inas experts discuss how to standardize and optimize your 3D cultures to fully automate your organoid workflows and deliver robust, reproducible results. Key takeaways include:
How to overcome the complexities of organoid imaging and assays
How to leverage label-free imaging and AI-based analysis for phenotypic profiling
How to screen 3D organoid models with high-content imaging and analysis
How cardioids can usher in the next generation of drug discovery
In this article, Labiotech.eu spoke with Susan Murphy, president of Molecular Devices, to find out how cardioids can improve research accuracy and lead to greater returns on drug discovery investment, and how we plan to take our customers from 2D to 3D models in this next generation of drug discovery.
What the transition away from animal testing could mean for drug discovery
In September, the U.S. Senate unanimously passed the FDA Modernization Act 2.0, which would lift an 84-year-old federal mandate for animal testing for toxicity studies. While the bill doesn’t ban animal testing outright, it would allow drug developers to use alternatives when feasible. To learn more about these alternatives, Drug Discovery & Development spoke with Susan Murphy, President of Molecular Devices, which works to enable high-throughput organoid research for life scientists.
In this Bio-IT World article, Molecular Devices Applications Scientist Angeline Lim and Core Life Analytics Chief Scientific Officer Victor Wong, Ph.D. discuss how AI-enabled analysis software helps researchers mine Cell Painting data effectively, perform predictive analytics, and easily access insights in perpetuity.
In April 2021, we launched our Organoid Innovation Centre (OIC), an initiative designed to help scientists leverage the potential of 3D biology throughout the drug discovery process.
On our one-year anniversary, Drug Discovery World’s Reece Armstrong spoke to Dan O’Connor, Vice President of Drug Discovery at Molecular Devices, about what the OIC offers to pharmaceutical companies and the advantages and barriers of 3D biology.
High-throughput IgG quantitation platform for clone screening during drug discovery and development
The accurate, rapid, and high-throughput measurement of recombinant monoclonal antibodies is essential during drug discovery and development. ValitTiter is a simple add-mix-read assay based on fluorescence polarization, for rapid quantification of Fc-containing immunoglobulins in cell culture supernatant and cell culture media.
During this webinar, we showcase how ValitaTiter plates can be used with our fluorescent polarization microplate readers to quantify IgG 4x faster than current ELISA and HPLC methods.
Interested in purchasing ValitaTiter plates from us directly?
Assure data integrity and compliance with confidence
Establishing a successful GMP/GLP lab requires complete solutions from a proven vendor who can help you set up a compliant laboratory quickly and confidently.
As a leader in comprehensive GxP compliance solutions, we've combined our widely cited microplate readers, industry-leading software, and expert services—all into powerful starter bundles to suit your specific requirements and get you started immediately.
Please be advised that this email may contain confidential information. If you are not the intended recipient, please notify us by email by replying to the sender and delete this message. The sender disclaims that the content of this email constitutes an offer to enter into, or the acceptance of, any agreement; provided that the foregoing does not invalidate the binding effect of any digital or other electronic reproduction of a manual signature that is included in any attachment.
.png?upscale=true&width=1120&upscale=true&name=MicrosoftTeams-image%20(14).png)
